What is Lumedica Vision?
Based in Durham, North Carolina, Lumedica Vision specializes in the development of high-precision optical coherence tomography (OCT) hardware and integrated artificial intelligence software. Their flagship product, the OQ EyeScope 2.0, represents a significant advancement in diagnostic capabilities, offering eye care professionals and clinical researchers a more accessible and efficient tool for patient assessment. By bridging the gap between complex imaging technology and practical clinical application, Lumedica Vision is effectively democratizing access to high-resolution ocular diagnostics, thereby improving patient outcomes through early detection and precise monitoring of eye conditions.
How much funding has Lumedica Vision raised?
Lumedica Vision has raised a total of $296K across 2 funding rounds:
Debt
$146K
Debt
$150K
Debt (2021): $146K with participation from PPP
Debt (2025): $150K led by Centrust Bank
Key Investors in Lumedica Vision
Centrust Bank
A financial institution providing commercial banking services and debt financing solutions to support corporate growth and operational stability.
PPP
Public-Private Partnership
What's next for Lumedica Vision?
The recent influx of capital signals a transition toward broader commercial deployment and the potential expansion of the company's AI-driven diagnostic suite. As Lumedica Vision moves deeper into its late-stage growth phase, the focus will likely shift toward scaling manufacturing operations and deepening its footprint in global clinical markets. By leveraging its proprietary OCT technology, the company is poised to address the growing demand for cost-effective, high-performance diagnostic tools, ensuring that its strategic initiatives remain aligned with the evolving needs of the modern healthcare infrastructure.
See full Lumedica Vision company page
